Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Browsing Tag

FDA

13 posts
NNestlé
Nestlé Joins the Microbiome Therapeutics Innovation Group (MTIG); Krys Araujo‑Torres, MD, MPP to Represent Company
Read More

Nestlé Joins the Microbiome Therapeutics Innovation Group (MTIG); Krys Araujo‑Torres, MD, MPP to Represent Company

  • 2026-05-02
BRIDGEWATER, N.J., April 29, 2026 /PRNewswire/ — Nestlé today announced it has joined the Microbiome Therapeutics Innovation Group (MTIG),…
RRoche
Biotech news from Roche, Amgen, Cassava
Read More

Readout Newsletter: Roche, Vertex, and J.D. Vance updates

  • 2026-04-20
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
NNovartis
Accelerators, Innovation Programs, Incubators, ICT, Technology Initiatives, Partnerships, Investments, Acquisitions, Network Map
Read More

Oligonucleotides Market Research and Competitive Landscape Report 2026 Featuring Novartis, Astellas, Alnylam Pharmaceuticals, Ionis Pharmaceuticals

  • 2026-04-16
Company Logo Key opportunities in the oligonucleotide market include advancing therapeutics for rare and diverse diseases like neurodegenerative…
RRoche
Institute of Human Biology by Roche
Read More

Organoids: new Roche research centre in Basel will focus on alternative model systems

  • 2026-03-25
The pharmaceutical group Roche is further expanding its research infrastructure in Switzerland, with a clear focus on novel…
RRoche
Roche's Mass Spectrometry Steroid Assays Receive FDA Moderate Complexity Designation
Read More

Roche’s Mass Spectrometry Steroid Assays Receive FDA Moderate Complexity Designation

  • 2026-03-18
Roche announced that the Food and Drug Administration has categorized its Ionify steroid assays for mass spectrometry as…
NNovartis
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting
Read More

Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa

  • 2026-03-15
Novartis Pharma AG Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism…
NNovartis
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting
Read More

Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa

  • 2026-03-13
Novartis Pharma AG Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism…
RRoche
Roche’s Gazyva Meets Phase III SLE Endpoints at 52 Weeks
Read More

Roche persevERA breast cancer trial misses goal

  • 2026-03-12
Roche (OTCQX: RHHBY) reported that the phase III persevERA study of giredestrant plus palbociclib in 1L ER+/HER2- advanced…
RRoche
Roche Receives FDA Nod for Lung Cancer Companion Diagnostic
Read More

Roche Receives FDA Nod for Lung Cancer Companion Diagnostic

  • 2026-02-28
Summary:The FDA has approved Roche’s VENTANA MET (SP44) RxDx Assay, the first companion diagnostic to identify MET protein…
RRoche
FDA Accepts Roche's NDA Seeking Approval for Breast Cancer Drug
Read More

FDA Accepts Roche’s NDA Seeking Approval for Breast Cancer Drug

  • 2026-02-25
Roche RHHBY announced that the FDA has accepted its new drug application (NDA) for giredestrant, an investigational oral therapy,…
RRoche
Roche fenebrutinib Phase III hits PPMS disability goal
Read More

Roche giredestrant NDA accepted by FDA for breast cancer

  • 2026-02-20
Roche (OTCQX: RHHBY) announced FDA acceptance of its New Drug Application for giredestrant…
RRoche
Jazz-Roche lung cancer combo approved by FDA
Read More

Jazz-Roche lung cancer combo approved by FDA

  • 2026-02-20
The U.S. FDA has approved the priority sNDA for a new first-line maintenance therapy in extensive-stage small-cell lung…
Switzerland
www.europesays.com